AMIKACIN SUSP,INHL
Clinical Criteria Summary
Exclusion Criteria
- Indication other than refractory Mycobacterium avium (MAC) pulmonary disease
Inclusion Criteria
- Prescriber is an Infectious Diseases or Pulmonary Specialist
- Patient has been treated with at least 6 months of guideline-based therapy without converting sputum cultures to negative (≥6-month final cultures remain positive)
- Patient has failed or is intolerant of parenteral aminoglycoside therapy or is not a candidate for such therapy
Discontinuation Criteria
- If the patient does not convert sputum cultures to negative with 6 months of ALIS + guideline-based therapy for refractory disease (≥6 month final culture results), therapy should be discontinued